Optimisation & Developability banner

The balance between optimizing a molecule’s therapeutic properties and ensuring its successful development lies at the heart of every biotherapeutic design. The 15th Annual Optimisation & Developability conference will delve into the strategies and cutting-edge tools used to navigate this challenge. Attendees will explore how to assess developability risks, tailor molecular properties for binding, specificity, half-life extension, stability, and formulation assessment for a variety of formats, using a toolbox of physics-based, in silico and machine learning approaches.

Recommended Short Course*
Monday, 4 November, 14:00 – 17:00
SC1: Developability of Bispecific Antibodies: Formats and Applications
*Separate registration required. See short courses page for details. All short courses take place in-person only.

For more details on the conference, please contact:

Mimi Langley
Senior Conference Director
Cambridge Healthtech Institute
Phone: (+1) 781-972-5439
Email: mlangley@healthtech.com

For sponsorship information, please contact:

Companies A-K
Jason Gerardi
Sr. Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5452
Email: jgerardi@healthtech.com

Companies L-Z
Ashley Parsons
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1340
Email: ashleyparsons@healthtech.com